Percentage of excess body mass index loss and cardiometabolic risk reduction in Peruvian adults undergoing sleeve gastrectomy

• Autores: Bardelli, María Luisa, Neciosup-Leon, Marycielo, Castilla-Espinoza, Carlos S., Torres-Pesantes, Luciana, Rodrigo-Gallardo, Paola K., Huamanchumo-Suyon, Medalit E., Bendezu-Quispe, Guido, Salinas-Sedo, Gustavo, Toro-Huamanchumo, Carlos J.
• Formato: artículo
• Fecha de Publicación: 2023
• Institución: Universidad Peruana de Ciencias Aplicadas
• Repositorio: UPC-Institucional
• Lenguaje: inglés
• OAI Identifier: oai:repositorioacademico.upc.edu.pe:10757/668039
• Enlace del recurso: http://hdl.handle.net/10757/668039
• Nivel de acceso: acceso embargado
• Materia: Bariatric surgery; Body mass index; Cardiovascular diseases; Metabolic syndrome; Peru; Excess Body Mass Index Loss (%EBMIL); Cardiometabolic risk reduction; Peruvian adults; Laparoscopic Sleeve Gastrectomy (LSG); Cholesterol; LDL (Low-Density Lipoprotein); VLDL (Very Low-Density Lipoprotein); Triglycerides; Glucose, Insulin, and HOMA-IR; Linear regression models

Objective: To assess the association between the percentage of excess body mass index loss (%EBMIL) and cardiometabolic risk reduction in Peruvian adults undergoing laparoscopic sleeve gastrectomy (LSG). Methods: Retrospective cohort study conducted with adult patients who underwent LSG in a bariatric clinic during 2016–2020. The outcome variable was cardiometabolic risk change (expressed in Δ) 1 year after LSG. To that effect, the variables total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein (LDL) cholesterol, very LDL (VLDL) cholesterol, triglycerides, glucose, insulin, and HOMA-IR at baseline and after 12 months were considered. The exposure variable was %EBMIL. Crude and adjusted β coefficients were estimated with linear regression models. Results: Of the 110 patients analyzed, 68.2% were women, and the median patient age was 34.5 years. In the model adjusted for sex, age, and baseline BMI, we noted that each 25% increase in %EBMIL resulted in a decrease in the values for total cholesterol, LDL, triglycerides, and insulin by 10.36 mg/dL (p < 0.001), 7.98 mg/dL (p = 0.001), 13.35 mg/dL (p = 0.033), and 3.63 uU/mL (p = 0.040), respectively. Conclusion: %EBMIL was associated with a decrease in total cholesterol, LDL, triglycerides, and insulin levels, which could suggest a favorable cardiometabolic evolution during the first 12 months following LSG.